Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. - Wikidata - awgldk - TriplyDB

Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.

Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.

http://www.wikidata.org/entity/Q36014872

about

Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?New agents for the treatment of hepatitis C in patients co-infected with HIV Joint modeling of HIV data in multicenter observational studies: A comparison among different approaches.Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection.Ending hepatitis C in the United States: the role of screening.Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems.Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia.Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection The hepatitis C treatment revolution: how to avoid Asia missing out Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder.Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1.What does the pharmacological future of treating chronic hepatitis C look like?Insurance status and mortality among patients with AIDS.The cost-effectiveness of treating triple coinfection with HIV, tuberculosis and hepatitis C virus.CD4 counts and mortality in virologically suppressed US veterans.The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.Advances in the treatment of HIV/HCV coinfection in adults.Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options.

P2860

Q26798469-382DBBC1-1A7B-4BF1-9199-7FC4934819E3 Q27006027-03841B98-69FB-45C7-B149-6985382EB2C1 Q30786463-07A9D011-514C-4BE4-9C80-A354476355F3 Q33576531-31AE18BF-B649-4227-8126-655AD973EC0E Q33862919-1A095452-03D1-4F40-BE44-86B2A0DB15A1 Q33926735-44DFC8E0-8107-4940-9E91-92CDCC44E32A Q34522213-619A7090-A5C9-40D0-9A69-1A96C05B6E07 Q34852032-44F44B3C-3ADA-44BA-9B04-89E2D68DE123 Q35072020-7EB47D92-102C-4D2C-8B7D-59C1CADF39B7 Q35861534-188A76F0-B704-483C-AE38-63FA9023C4A0 Q36213126-89D715BB-BC21-45A3-AFBC-44001AF74F3D Q36399193-2AFC2E11-06CF-487B-8CA8-FC094C4CBCAA Q37042436-783E6A16-97E7-47BA-8436-AC5CA9E86032 Q37091595-81499FF4-C1C0-42FB-9B0D-372F6A33C8D0 Q37098184-5A37C66E-BC60-4FDB-80D1-FC9A0719F223 Q37272287-E4F50D54-E041-4164-8B72-5902EE377360 Q37625493-2307F9EE-61D3-47EC-9933-6EEB3C61E9C1 Q37642114-4E91DBDF-FB60-4464-90C3-8BB5602CDFC0 Q38153794-5ED3FEAB-D26A-435E-AB7E-47A62C6087B6 Q38569681-AC920754-4B3F-4526-ACBD-2C1E89DBADE3 Q40127748-50C79CC7-EBFC-45DB-836D-777E62CE7553 Q40711194-5594E00C-D557-4E2C-908E-0FF43452CDC3 Q42246080-E87395E7-3672-4CBE-8A12-21816D9D01BA Q46623464-FFD2A484-3629-4188-B343-BA89FE77BE2C Q47291511-5347FD72-B3B0-42E4-ABE1-AFEF0FEC4D4F Q54243856-E82627ED-7742-40C2-B2C0-5AB8DB9DC9C2

P2860

Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.

http://www.wikidata.org/entity/Q36014872

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Mortality in hepatitis C virus ...... nation antiretroviral therapy.

@ast

Mortality in hepatitis C virus ...... nation antiretroviral therapy.

@en

type

label

Mortality in hepatitis C virus ...... nation antiretroviral therapy.

@ast

Mortality in hepatitis C virus ...... nation antiretroviral therapy.

@en

prefLabel

Mortality in hepatitis C virus ...... nation antiretroviral therapy.

@ast

Mortality in hepatitis C virus ...... nation antiretroviral therapy.

@en

P1433

Q36014872-7050C111-BD81-4FF1-B361-075368F4D45A

P1476

Q36014872-57B948EF-1409-4856-AE41-51D34355CC2A

P2093

Q36014872-0D33802D-5342-41CD-93BD-0AE76BCD1514

Q36014872-44D39586-8C6D-4BB9-8D62-97EBBC8F2210

Q36014872-5AD1B4C3-8FBD-42A8-BF23-C2FE93560A72

Q36014872-676BA7DE-A0D6-495E-95F2-5DC83981FAE3

Q36014872-B034B160-0455-4C22-B82C-0EFA4A909842

Q36014872-E2E8E5FB-209D-4292-9F21-E4016936BC8F

Q36014872-EC3603BA-F27A-4578-95B9-2C8183CF3CA0

P2860

Q36014872-010A2BD6-FACC-4C7E-B82E-57BD62900F30

Q36014872-0D5E9A96-4A9F-4F05-AEFC-981DF5CBB759

Q36014872-1CB4048D-13AA-48FA-85BF-698539E9BD1E

Q36014872-1FCD1A63-3BDA-4495-AD4B-9C60FD2291FE

Q36014872-2041FB1F-2EAC-431A-8F9C-79EC1C35F631

Q36014872-226F9CE3-9ED2-4137-AB08-AF90206DE2AD

Q36014872-357C42B1-A88F-4387-B1BA-D652625EEB52

Q36014872-3899437D-9D71-4095-9EBE-D42CAB7F8442

Q36014872-3AABE900-4DE6-4A76-B5ED-982766957F72

Q36014872-3BE9F72D-6B85-45ED-BC3B-ECF07B29BDCF

P304

Q36014872-6F3927C3-E734-4C9F-99AD-4B6C98E0B5C0

P31

Q36014872-DA98DB24-D71D-44E3-ADA2-757020759A30

P356

Q36014872-E8167F0A-1306-4883-9D48-BC81B81E3091

P407

Q36014872-17B9ADF8-12B8-4F88-976F-F406177DFC47

P433

Q36014872-542E1DF1-60FA-4A28-86E0-0DC582EFB5D2

P478

Q36014872-D08F741E-4F18-4D0A-88CE-5C6C73F48B12

P577

Q36014872-8B996F53-F09B-4D4C-B073-B060B0014B09

P5875

Q36014872-F6EBC2C0-D41A-47E5-A9AE-D7CE0766C49D

P698

Q36014872-6B4E41C5-59EF-4228-A54F-16A119B585D6

P921

Q36014872-3BC14954-C508-4FAA-BD59-09CBDF7F04D3

Q36014872-5D85B245-013F-4D65-BB2E-5E70F72FB769

Q36014872-D44A166A-37E2-4CBC-9884-372944188CB8

P932

Q36014872-D18667EC-9631-4A85-A0C7-C00B493810D6

P356

P1433

Clinical Infectious Diseases

P1476

Mortality in hepatitis C virus ...... nation antiretroviral therapy.

@en

P2093

Andrea D Branch

http://www.w3.org/2001/XMLSchema#string

Curtis L Meinert

http://www.w3.org/2001/XMLSchema#string

Douglas A Jabs

http://www.w3.org/2001/XMLSchema#string

Douglas T Dieterich

http://www.w3.org/2001/XMLSchema#string

Marie-Louise Vachon

http://www.w3.org/2001/XMLSchema#string

Mark L Van Natta

http://www.w3.org/2001/XMLSchema#string

Studies of the Ocular Complications of AIDS Research Group

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.

High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities

Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy.

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Awareness of hepatitis C infection among women with and at risk for HIV.

Public health impact of antiviral therapy for hepatitis C in the United States.

The economic implications of broader sharing of liver allografts.

Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.

P304

137-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIS404

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224848872

http://www.w3.org/2001/XMLSchema#string

P698

22534149

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3369565

http://www.w3.org/2001/XMLSchema#string